Economic Studies of FDA Regulations

The Food and Drug Administration seeks to contract economic studies of FDA regulations to conduct baseline industry assessments, estimate economic costs and risk reductions of regulations, analyze effects on innovation and small businesses, develop adaptable assessment methods and databases, and consult with industry experts. Responses are requested from small businesses by February 23, 2024 to identify capabilities and be considered for the anticipated five-year contract period beginning after publication of a formal solicitation.

There is no set-aside designated for this opportunity. Potentially applicable NAICS codes include 541611, 541618, and 541715. Key details include conducting assessments, estimating economic impacts, and analyzing effects on industries over a five-year period to support FDA regulatory analyses. The budget range and value of the contract were not specified.